mimedx-logo-spot.jpg
MiMedx Awarded Amniotic Tissue Supplier Agreement with Premier® Inc.’s SURPASS™ Purchasing Program
March 30, 2021 08:00 ET | MiMedx Group, Inc
MARIETTA, Ga., March 30, 2021 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MiMedx” or the “Company”), an industry leader in utilizing birth tissue as a platform for regenerative medicine,...
mimedx-logo-spot.jpg
MiMedx Announces Appointment of Phyllis Gardner, M.D. to Board of Directors
March 08, 2021 17:33 ET | MiMedx Group, Inc
Noted biopharmaceutical thought leader adds academic, research and industry expertise MARIETTA, Ga., March 08, 2021 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MiMedx” or the...
mimedx-logo-spot.jpg
MiMedx Announces Fourth Quarter and Full Year 2020 Financial and Operating Results
March 08, 2021 17:32 ET | MiMedx Group, Inc
Fourth Quarter Net Sales of $68.5 million, Full Year 2020 Net Sales of $248.2 million Company to Host Conference Call on March 9, 2021 at 9:30 AM ET MARIETTA, Ga., March 08, 2021 (GLOBE NEWSWIRE)...
mimedx-logo-spot.jpg
MiMedx to Participate at Upcoming Investor Conferences
March 03, 2021 08:00 ET | MiMedx Group, Inc
MARIETTA, Ga., March 03, 2021 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MiMedx” or the “Company”), an industry leader in advanced wound care and a therapeutic biologics company, today...
mimedx-logo-spot.jpg
MiMedx to Host Fourth Quarter and Full Year 2020 Operating and Financial Results Conference Call on March 9
March 02, 2021 08:00 ET | MiMedx Group, Inc
MARIETTA, Ga., March 02, 2021 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MiMedx” or the “Company”), an industry leader in advanced wound care and a therapeutic biologics company, today...
mimedx-logo-spot.jpg
MiMedx to Participate at the BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference
February 10, 2021 08:00 ET | MiMedx Group, Inc
MARIETTA, Ga., Feb. 10, 2021 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MiMedx” or the “Company”), an industry leader in advanced wound care and a therapeutic biologics company, today...
mimedx-logo-spot.jpg
Reminder: MiMedx to Present at the 39th Annual J.P. Morgan Healthcare Conference
January 06, 2021 08:00 ET | MiMedx Group, Inc
MARIETTA, Ga., Jan. 06, 2021 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MiMedx” or the “Company”), an industry leader in advanced wound care and a therapeutic biologics company, today...
mimedx-logo-spot.jpg
MiMedx to Participate at the H.C. Wainwright BioConnect 2021 Conference
January 04, 2021 08:00 ET | MiMedx Group, Inc
MARIETTA, Ga., Jan. 04, 2021 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MiMedx” or the “Company”), an industry leader in advanced wound care and a therapeutic biologics company, today...
mimedx-logo-spot.jpg
MiMedx to Present at the 39th Annual J.P. Morgan Healthcare Conference
December 07, 2020 08:00 ET | MiMedx Group, Inc
MARIETTA, Ga., Dec. 07, 2020 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MiMedx” or the “Company”), an industry leader in advanced wound care and a therapeutic biologics company, today...
mimedx-logo-spot.jpg
MiMedx Appoints Jack Howarth as Senior Vice President, Investor Relations
December 01, 2020 09:22 ET | MiMedx Group, Inc
Experienced Healthcare Executive Will Expand Company’s Visibility Within the Financial Community MARIETTA, Ga., Dec. 01, 2020 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (NASDAQ: MDXG) (“MiMedx” or the...